niftify.in

niftify.in

Latest Strides Pharma Science News

Stay Informed on Strides Pharma Science Stock News: Access the latest Strides Pharma Science stock news, industry updates, and quick information on Strides Pharma Science stock buybacks,Strides Pharma Science results, Strides Pharma Science company analysis, Strides Pharma Science live prices, Strides Pharma Science dividends, Strides Pharma Science bonus share, board meetings, lifetime highs, Strides Pharma Science targets, lows, and growth stories with AI—all in one place.

Star India, owned by Walt Disney, has sought $940 million in damages from Zee Entertainment for not honoring a $1.5 billion ICC TV rights deal. Zee refuted the claims and stated that arbitration is still in its initial stages. The matter will likely continue post Star's merger with Viacom18.
The Economic Times

The Economic Times

Star claims $940 million damages from ZEE over failed deal

Star India, owned by Walt Disney, has sought $940 million in damages from Zee Entertainment for not honoring a $1.5 billion ICC TV rights deal. Zee refuted the claims and stated that arbitration is still in its initial stages. The matter will likely continue post Star's merger with Viacom18.

Wed, Sep 18, 2024

The dispute is about Zee not meeting payment deadlines of a $1.4 billion licensing deal with Star, which gives exclusive TV rights for ICC men’s matches
Hindustan Times

Hindustan Times

Disney Star seeks $940 million in damages from Zee for not meeting ICC broadcasting rights payment deadlines

The dispute is about Zee not meeting payment deadlines of a $1.4 billion licensing deal with Star, which gives exclusive TV rights for ICC men’s matches

Wed, Sep 18, 2024

ZEEL's stock fell 1.35 per cent to Rs 131.20 a piece on NSE
Business Standard

Business Standard

ZEEL refutes Disney Star's $940 mn damages over failed ICC TV rights deal

ZEEL's stock fell 1.35 per cent to Rs 131.20 a piece on NSE

Wed, Sep 18, 2024

The dispute centres on an alliance agreement between Zee and Star India valued at $1.4 billion for the broadcasting rights for International Cricket Council (ICC) events
Business Standard

Business Standard

Zee Entertainment refutes $940 million damages claim by Disney's Star India

The dispute centres on an alliance agreement between Zee and Star India valued at $1.4 billion for the broadcasting rights for International Cricket Council (ICC) events

Wed, Sep 18, 2024

Zee Entertainment Enterprises has categorically refuted all claims and assertions made by Star India including its claims for damages.
CNBC TV18

CNBC TV18

Zee Entertainment will contest ₹8,000 crore claims made by Star India; Shares fall

Zee Entertainment Enterprises has categorically refuted all claims and assertions made by Star India including its claims for damages.

Wed, Sep 18, 2024

Star India has filed a Statement of Case against Zee Entertainment, seeking $940 million in damages over a terminated ICC TV rights deal. Zee denies the allegations and plans to contest the claims. The arbitration is still in its early stages, with the LCIA Tribunal yet to determine Zee's liability.
The Economic Times

The Economic Times

Star files Statement of Case in London court against ZEE, seeks $940 million in damages

Star India has filed a Statement of Case against Zee Entertainment, seeking $940 million in damages over a terminated ICC TV rights deal. Zee denies the allegations and plans to contest the claims. The arbitration is still in its early stages, with the LCIA Tribunal yet to determine Zee's liability.

Wed, Sep 18, 2024

Vakrangee rallied 5.59% to Rs 22.11 after the company informed strategic corporate agency tie-up with Star Health & Allied Insurance Co. (Star Health Insurance), to offer health insurance products across its network.
Business Standard

Business Standard

Vakrangee jumps after joining hands with Star Health Insurance

Vakrangee rallied 5.59% to Rs 22.11 after the company informed strategic corporate agency tie-up with Star Health & Allied Insurance Co. (Star Health Insurance), to offer health insurance products across its network.

Wed, Sep 18, 2024

Star Cement Ltd., incorporated in the year 2001, is a Mid Cap company (having a market cap of Rs 8568.62 Crore) operating in Cement sector.
The Economic Times

The Economic Times

Buy Star Cement, target price Rs 250: Axis Securities

Star Cement Ltd., incorporated in the year 2001, is a Mid Cap company (having a market cap of Rs 8568.62 Crore) operating in Cement sector.

Tue, Sep 17, 2024

Strides Pharma Science Ltd on Monday said its arm has received approval from the US health regulator for its generic version of antidepressant Fluoxetine tablets.
The approval granted by the US Food & Drug Administration (USFDA) to wholly owned subsidiary Strides Pharma Global Pte. Ltd, Singapore, is for Fluoxetine tablets of strength 60 mg, Strides Pharma Science said in a regulatory filing.
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Fluoxetine tablets, 60 mg, of TWi Pharmaceuticals, Inc, it added.
The Fluoxetine tablets will be manufactured at the company's facility in Puducherry, Strides said.
With the approval of the Fluoxetine Tabs 60 mg strength, the company is now positioned to offer a complete portfolio of Fluoxetine across capsules and tablets in 10 mg, 20 mg, and 60 mg strengths, it added.
The addition of the Fluoxetine tablets 60 mg will allow for enhanced flexibility in dosing, catering to a broader spectrum of ...
Business Standard

Business Standard

Strides Pharma Science gets USFDA nod for generic antidepressant tablets

Strides Pharma Science Ltd on Monday said its arm has received approval from the US health regulator for its generic version of antidepressant Fluoxetine tablets. The approval granted by the US Food & Drug Administration (USFDA) to wholly owned subsidiary Strides Pharma Global Pte. Ltd, Singapore, is for Fluoxetine tablets of strength 60 mg, Strides Pharma Science said in a regulatory filing. The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Fluoxetine tablets, 60 mg, of TWi Pharmaceuticals, Inc, it added. The Fluoxetine tablets will be manufactured at the company's facility in Puducherry, Strides said. With the approval of the Fluoxetine Tabs 60 mg strength, the company is now positioned to offer a complete portfolio of Fluoxetine across capsules and tablets in 10 mg, 20 mg, and 60 mg strengths, it added. The addition of the Fluoxetine tablets 60 mg will allow for enhanced flexibility in dosing, catering to a broader spectrum of ...

Mon, Sep 16, 2024

Shares of Strides Pharma Science Ltd ended at ₹1,391.55, up by ₹38.05, or 2.81%, on the BSE.
CNBC TV18

CNBC TV18

Strides Pharma receives approval to expand antidepressant line in the US

Shares of Strides Pharma Science Ltd ended at ₹1,391.55, up by ₹38.05, or 2.81%, on the BSE.

Mon, Sep 16, 2024

Strides Pharma Science announced that its step-down wholly owned subsidiary, Strides Pharma Global, Singapore, has received approval for Fluoxetine Tabs 60 mg, from the United States Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Fluoxetine Tablets, 60 mg, of TWi Pharmaceuticals, Inc.
Business Standard

Business Standard

Strides receives USFDA approval for Fluoxetine Tabs 60 mg

Strides Pharma Science announced that its step-down wholly owned subsidiary, Strides Pharma Global, Singapore, has received approval for Fluoxetine Tabs 60 mg, from the United States Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Fluoxetine Tablets, 60 mg, of TWi Pharmaceuticals, Inc.

Mon, Sep 16, 2024

Blue Star share price can rise to ₹2,050-₹2,100
Business Line

Business Line

Stock to buy today: Blue Star (₹1,887.65): BUY

Blue Star share price can rise to ₹2,050-₹2,100

Mon, Sep 16, 2024

Three new IPOs, Bajaj Housing Finance, Kross Ltd, and Tolins Tyres, are set to debut on Monday. Bajaj Housing Finance is expected to be the star performer, with a grey market premium of 113%. All three issues are anticipated to generate positive returns for investors, but grey market premiums can be volatile and should be considered cautiously.
The Economic Times

The Economic Times

Listing gains could soar up to 113% as Street awaits debut of Bajaj Housing Finance, 2 other IPOs

Three new IPOs, Bajaj Housing Finance, Kross Ltd, and Tolins Tyres, are set to debut on Monday. Bajaj Housing Finance is expected to be the star performer, with a grey market premium of 113%. All three issues are anticipated to generate positive returns for investors, but grey market premiums can be volatile and should be considered cautiously.

Fri, Sep 13, 2024

The startup that provides digital infrastructure to hospitals for processing insurance claims and assists patients in getting faster pay-outs was praised for its mission to improve a massive pain point for users.
The Economic Times

The Economic Times

ET Startup Awards 2024 | Best on Campus: ClaimBuddy stays on pulse to take home campus star prize

The startup that provides digital infrastructure to hospitals for processing insurance claims and assists patients in getting faster pay-outs was praised for its mission to improve a massive pain point for users.

Star Cement Ltd. key Products/Revenue Segments include Cement, Other Operating Revenue, Others and Scrap for the year ending 31-Mar-2023.
The Economic Times

The Economic Times

Buy Star Cement, target price Rs 257: ICICI Securities

Star Cement Ltd. key Products/Revenue Segments include Cement, Other Operating Revenue, Others and Scrap for the year ending 31-Mar-2023.

Thu, Sep 12, 2024

Strides Pharma Science on Wednesday said it has received approval from shareholders and secured creditors for creation of OneSource -- a specialty pharma CDMO (contract development and manufacturing organization).
The company has secured the approval of its shareholders and secured creditors with overwhelming majority, along with those of OneSource Specialty Pharma and SteriScience Specialties, in meetings convened under the guidance of the National Company Law Tribunal, it said in a regulatory filing.
All the secured creditors who voted on the scheme for the three companies in their respective meetings were in favour of the scheme, it added.
"We believe OneSource will unlock considerable value for Strides' stakeholders upon its listing. We remain committed to delivering on this promise and express our gratitude to our shareholders and creditors for their continued trust and support," Strides Pharma Science Executive Chairperson Arun Kumar said.
In September 2023, Strides announced
Business Standard

Business Standard

Strides Pharma gets shareholders' nod to set up speciality pharma CDMO

Strides Pharma Science on Wednesday said it has received approval from shareholders and secured creditors for creation of OneSource -- a specialty pharma CDMO (contract development and manufacturing organization). The company has secured the approval of its shareholders and secured creditors with overwhelming majority, along with those of OneSource Specialty Pharma and SteriScience Specialties, in meetings convened under the guidance of the National Company Law Tribunal, it said in a regulatory filing. All the secured creditors who voted on the scheme for the three companies in their respective meetings were in favour of the scheme, it added. "We believe OneSource will unlock considerable value for Strides' stakeholders upon its listing. We remain committed to delivering on this promise and express our gratitude to our shareholders and creditors for their continued trust and support," Strides Pharma Science Executive Chairperson Arun Kumar said. In September 2023, Strides announced

Wed, Sep 11, 2024

Strides Pharma Science has received approval from shareholders and secured creditors to create OneSource, a specialty pharma CDMO. The company will now seek final approval from the NCLT, Mumbai Bench, and listing approvals from BSE and NSE. This move aims to unlock value for stakeholders upon OneSource's listing.
The Economic Times

The Economic Times

Strides secures shareholders' nod for OneSource specialty CDMO unit

Strides Pharma Science has received approval from shareholders and secured creditors to create OneSource, a specialty pharma CDMO. The company will now seek final approval from the NCLT, Mumbai Bench, and listing approvals from BSE and NSE. This move aims to unlock value for stakeholders upon OneSource's listing.

Wed, Sep 11, 2024

Strides Pharma Science (Strides) today announced that it has secured the approval of its equity shareholders and secured creditors with overwhelming majority , along with those of OneSource Specialty Pharma and SteriScience Specialties, in meetings convened under the guidance of the Hon'ble National Company Law Tribunal (NCLT). All the secured creditors who voted on the Scheme for the three Companies in their respective meetings, were in favour of the Scheme.
Business Standard

Business Standard

Strides secures approval of shareholders and creditors for creation of OneSource

Strides Pharma Science (Strides) today announced that it has secured the approval of its equity shareholders and secured creditors with overwhelming majority , along with those of OneSource Specialty Pharma and SteriScience Specialties, in meetings convened under the guidance of the Hon'ble National Company Law Tribunal (NCLT). All the secured creditors who voted on the Scheme for the three Companies in their respective meetings, were in favour of the Scheme.

Wed, Sep 11, 2024

​Navya Naveli, Jahnavi Mehta, and 4 more star kids who chose to carve their own unique paths outside the film industry, opting for careers beyond Bollywood fame."​
The Economic Times

The Economic Times

Navya Naveli, Jahnavi Mehta & others: 6 Bollywood star kids who stepped away from films

​Navya Naveli, Jahnavi Mehta, and 4 more star kids who chose to carve their own unique paths outside the film industry, opting for careers beyond Bollywood fame."​

Tue, Sep 10, 2024

Unlocking growth potential in the used commercial vehicle segment through scrappage policy, driving demand and affordability for buyers
Business Line

Business Line

Affordability and scrappage policy fuel growth in used truck market: IndoStar Capital CEO

Unlocking growth potential in the used commercial vehicle segment through scrappage policy, driving demand and affordability for buyers

Mon, Sep 9, 2024

Ahead of the issue opening, Gala Precision Engineering raised ₹50 crore from anchor investors including Negen Undiscovered Value Fund, NAV Capital Emerging Star Fund, Cognizant Capital Dynamic Opportunities Fund, among others.
CNBC TV18

CNBC TV18

Gala Precision Engineering, the second-most subscribed IPO of 2024, lists at 42% premium on BSE

Ahead of the issue opening, Gala Precision Engineering raised ₹50 crore from anchor investors including Negen Undiscovered Value Fund, NAV Capital Emerging Star Fund, Cognizant Capital Dynamic Opportunities Fund, among others.

Mon, Sep 9, 2024

Apple is expected to release its latest line of iPhones on Monday that will feature generative AI capabilities as the tech behemoth looks to bolster sales of its iconic device. By adding AI capabilities, Apple is looking to "shake that expectation" that iPhone launches are  "just steady improvements in hardware and software,"  said Techsponential analyst Avi Greengart.
The Economic Times

The Economic Times

Apple AI expected to star as new iPhones are unveiled

Apple is expected to release its latest line of iPhones on Monday that will feature generative AI capabilities as the tech behemoth looks to bolster sales of its iconic device. By adding AI capabilities, Apple is looking to "shake that expectation" that iPhone launches are "just steady improvements in hardware and software," said Techsponential analyst Avi Greengart.

Mon, Sep 9, 2024

Geojit Financial
Business Line

Business Line

Broker’s call: Star Health (Buy)

Geojit Financial

Fri, Sep 6, 2024

Strides Pharma Science Ltd announced that its subsidiary has received approval from the USFDA for its generic version of Theophylline extended-release tablets, used to manage chronic asthma and other respiratory conditions. The tablets, available in 300 mg and 450 mg doses, will be produced at their Bengaluru facility and have a market size of around USD 11.5 million.
The Economic Times

The Economic Times

Strides gets USFDA nod for Theophylline extended-release tablets

Strides Pharma Science Ltd announced that its subsidiary has received approval from the USFDA for its generic version of Theophylline extended-release tablets, used to manage chronic asthma and other respiratory conditions. The tablets, available in 300 mg and 450 mg doses, will be produced at their Bengaluru facility and have a market size of around USD 11.5 million.

Fri, Sep 6, 2024

Esports World Cup: Social media influencers promoted the World Cup content, gathering a reach of more than 39 million. Popular creator Rishabh Shukla’s reel was watched 20.3 million times alone, Star Sports, the official broadcast partner of EWC told ET.
The Economic Times

The Economic Times

Esports World Cup reached over 10.5 million Indians: BARC

Esports World Cup: Social media influencers promoted the World Cup content, gathering a reach of more than 39 million. Popular creator Rishabh Shukla’s reel was watched 20.3 million times alone, Star Sports, the official broadcast partner of EWC told ET.

Fri, Sep 6, 2024

Liquor maker Allied Blenders and Distillers has partnered with Bollywood star Ranveer Singh to start a new business venture to offer a portfolio of premium brands.
The board of Allied Blenders and Distillers Ltd (ABDL) has approved the formation of the new venture on Wednesday, said a statement from the company.
"The creation of this would mark a strategic move for ABDL, allowing the new venture to focus on the exciting world of luxury spirits, while retaining the existing core brands in ABDL itself," said a joint statement
With Indians drinking better and trending to luxury products, this business is set to make a significant impact.
"The entity will launch its own brands, partner with promising Indian start-ups, work with major international brands, and use the strong ABDL sales and manufacturing networks with clear go-to-market strategies," it said.
ABDL Managing Director Alok Gupta said: "This new venture, with the major impact personality like Ranveer Singh, represents our ..
Business Standard

Business Standard

Allied Blenders, Ranveer Singh to start new venture in premium segment

Liquor maker Allied Blenders and Distillers has partnered with Bollywood star Ranveer Singh to start a new business venture to offer a portfolio of premium brands. The board of Allied Blenders and Distillers Ltd (ABDL) has approved the formation of the new venture on Wednesday, said a statement from the company. "The creation of this would mark a strategic move for ABDL, allowing the new venture to focus on the exciting world of luxury spirits, while retaining the existing core brands in ABDL itself," said a joint statement With Indians drinking better and trending to luxury products, this business is set to make a significant impact. "The entity will launch its own brands, partner with promising Indian start-ups, work with major international brands, and use the strong ABDL sales and manufacturing networks with clear go-to-market strategies," it said. ABDL Managing Director Alok Gupta said: "This new venture, with the major impact personality like Ranveer Singh, represents our ..

Thu, Sep 5, 2024

Allied Blenders and Distillers has teamed up with Bollywood star Ranveer Singh to launch a new venture focused on premium brands. The initiative aims to cater to the growing demand for luxury spirits in India, leveraging ABDL's sales and manufacturing networks and collaborating with Indian start-ups and international brands.
The Economic Times

The Economic Times

Allied Blenders partners Ranveer Singh to start new venture in premium segment

Allied Blenders and Distillers has teamed up with Bollywood star Ranveer Singh to launch a new venture focused on premium brands. The initiative aims to cater to the growing demand for luxury spirits in India, leveraging ABDL's sales and manufacturing networks and collaborating with Indian start-ups and international brands.

Thu, Sep 5, 2024

The policy is designed to address the specific requirements of individuals with disabilities of 40% or more, including physical, sensory, or cognitive impairments
Business Standard

Business Standard

Star Health introduces braille insurance policy for visually impaired

The policy is designed to address the specific requirements of individuals with disabilities of 40% or more, including physical, sensory, or cognitive impairments

Thu, Sep 5, 2024

The collaboration aims to introduce a range of premium and luxury spirit brands tailored to the Indian market.
Business Line

Business Line

Allied Blenders and Distillers partner with Bollywood star Ranveer Singh for premium spirits venture

The collaboration aims to introduce a range of premium and luxury spirit brands tailored to the Indian market.

Thu, Sep 5, 2024

Star Health and Allied Insurance Co. Ltd. plans to diversify into term and motor insurance markets by leveraging its existing health insurance portfolio. The company aims to apply for a composite insurance license once the Insurance Act is amended, targeting a total book growth to Rs 30,000 crore by 2028.
The Economic Times

The Economic Times

Star Health wants to apply for composite license to enter pure term and motor insurance space

Star Health and Allied Insurance Co. Ltd. plans to diversify into term and motor insurance markets by leveraging its existing health insurance portfolio. The company aims to apply for a composite insurance license once the Insurance Act is amended, targeting a total book growth to Rs 30,000 crore by 2028.

Wed, Sep 4, 2024

Launches Braille version of health insurance policy; The firm will to train and upskill visually-impaired individuals to enable them to become and absorb them as health insurance agents
Business Line

Business Line

Star Health Insurance plans to double business in four years, launches policy in Braille

Launches Braille version of health insurance policy; The firm will to train and upskill visually-impaired individuals to enable them to become and absorb them as health insurance agents

Wed, Sep 4, 2024

Star Health Insurance has launched an industry-first insurance policy in Braille, aimed at visually-impaired individuals. The 'Special Care Gold' policy, created with the National Association of the Blind, offers tailored coverage for those with 40% or more disability. This initiative aims to provide inclusive health coverage and support services for a critical but underserved segment of customers.
The Economic Times

The Economic Times

Star Health launches insurance policy in Braille

Star Health Insurance has launched an industry-first insurance policy in Braille, aimed at visually-impaired individuals. The 'Special Care Gold' policy, created with the National Association of the Blind, offers tailored coverage for those with 40% or more disability. This initiative aims to provide inclusive health coverage and support services for a critical but underserved segment of customers.

Wed, Sep 4, 2024

Star Health policy, available in Braille format, offers health cover for individuals with 40 per cent and above disability
Business Line

Business Line

Star Health launches insurance policy in Braille

Star Health policy, available in Braille format, offers health cover for individuals with 40 per cent and above disability

Wed, Sep 4, 2024

The Indian Premier League's (IPL) business value has decreased by 11.7% to $9.9 billion in 2024 due to a reassessment of media rights and industry consolidation. The merger between Star India and Viacom18, along with the delay in tech giants entering the bidding, has contributed to this decline.
The Economic Times

The Economic Times

IPL valuation down by 11.7% on weak media rights score

The Indian Premier League's (IPL) business value has decreased by 11.7% to $9.9 billion in 2024 due to a reassessment of media rights and industry consolidation. The merger between Star India and Viacom18, along with the delay in tech giants entering the bidding, has contributed to this decline.

Tue, Sep 3, 2024

Leading French cosmetic maker L'Oreal Paris on Tuesday said it has roped in Bollywood actress Alia Bhatt as its new global brand ambassador.
With this, Bhatt joins the brand's diverse roster of L'Oreal brand ambassadors like Viola Davis, Jane Fonda, Eva Longoria, Kendall Jenner, Elle Fanning, Camila Cabello, and many others.
She will star in the French beauty brand's campaigns, starting in September 2024, said a L'Oreal statement.
Bhatt embodies the core values of L'Oreal Paris, representing inclusivity and empowerment, sharing the transformative power of self-belief with women all over the world, it said.
L'Oreal Paris Global President Delphine Viguier-Hovasse said: "I admire how Alia uses her global platform and role as a producer to push for inclusivity in the film industry and to shed light on Indian cinema worldwide.
"Her commitment to care for people and the planet makes her the perfect ambassador for female talent, entrepreneurship, and for the endless possibilities L'Oreal
Business Standard

Business Standard

L'Oreal Paris ropes in actor Alia Bhatt as new global brand ambassador

Leading French cosmetic maker L'Oreal Paris on Tuesday said it has roped in Bollywood actress Alia Bhatt as its new global brand ambassador. With this, Bhatt joins the brand's diverse roster of L'Oreal brand ambassadors like Viola Davis, Jane Fonda, Eva Longoria, Kendall Jenner, Elle Fanning, Camila Cabello, and many others. She will star in the French beauty brand's campaigns, starting in September 2024, said a L'Oreal statement. Bhatt embodies the core values of L'Oreal Paris, representing inclusivity and empowerment, sharing the transformative power of self-belief with women all over the world, it said. L'Oreal Paris Global President Delphine Viguier-Hovasse said: "I admire how Alia uses her global platform and role as a producer to push for inclusivity in the film industry and to shed light on Indian cinema worldwide. "Her commitment to care for people and the planet makes her the perfect ambassador for female talent, entrepreneurship, and for the endless possibilities L'Oreal

Tue, Sep 3, 2024

The newly merged Star India-Viacom18 will have over Rs 19,000 crore in cash reserves, enabling the company to invest in its digital and sports sectors, which may face short-term losses
Business Standard

Business Standard

Newly merged Star India-Viacom18 to boast cash reserves of over Rs 19K cr

The newly merged Star India-Viacom18 will have over Rs 19,000 crore in cash reserves, enabling the company to invest in its digital and sports sectors, which may face short-term losses

Tue, Sep 3, 2024

As per the agreement with Walt Disney, RIL will inject ₹11,500 crore into Star-Viacom18, gaining a controlling 56% stake. Walt Disney will hold a 37% stake, with the remaining 7% owned by Uday Shankar and James Murdoch's Bodhi Tree Systems.
The Economic Times

The Economic Times

Merged star India-Viacom18 to be cash rich by over Rs 19k cr

As per the agreement with Walt Disney, RIL will inject ₹11,500 crore into Star-Viacom18, gaining a controlling 56% stake. Walt Disney will hold a 37% stake, with the remaining 7% owned by Uday Shankar and James Murdoch's Bodhi Tree Systems.

Mon, Sep 2, 2024

Gala Precision Engineering opens today: Ahead of the issue opening, the company has raised ₹50 crore from anchor investors including Negen Undiscovered Value Fund, NAV Capital Emerging Star Fund, Cognizant Capital Dynamic Opportunities Fund, among others.
CNBC TV18

CNBC TV18

Gala Precision Engineering opens for subscription: Should you bid?

Gala Precision Engineering opens today: Ahead of the issue opening, the company has raised ₹50 crore from anchor investors including Negen Undiscovered Value Fund, NAV Capital Emerging Star Fund, Cognizant Capital Dynamic Opportunities Fund, among others.

Mon, Sep 2, 2024

The investment will cover the licensing fee to the US-based Space Exploration and Research Agency (SERA) as well as production and talent costs, they added. Industry watchers said 'Bigg Boss Hindi', hosted by Bollywood star Salman Khan, is currently the country's most expensive non-fiction show, with budgets exceeding Rs 150 crore.
The Economic Times

The Economic Times

'First-of-its-kind' space travel reality series to get $50 million from Banijay Asia

The investment will cover the licensing fee to the US-based Space Exploration and Research Agency (SERA) as well as production and talent costs, they added. Industry watchers said 'Bigg Boss Hindi', hosted by Bollywood star Salman Khan, is currently the country's most expensive non-fiction show, with budgets exceeding Rs 150 crore.

Sun, Sep 1, 2024

James Hewing, National Motorcycle Museum director, shares his journey from amateur racing to overseeing the world's largest collection of British bikes. He discusses his role in the relaunch of the BSA and its Gold Star motorbike under Classic Legends by Mahindra, emphasizing the crucial role Indian companies play in reviving classic brands.
The Economic Times

The Economic Times

In a disposable world, retro motorcycles have an eternally cool factor: James Hewing

James Hewing, National Motorcycle Museum director, shares his journey from amateur racing to overseeing the world's largest collection of British bikes. He discusses his role in the relaunch of the BSA and its Gold Star motorbike under Classic Legends by Mahindra, emphasizing the crucial role Indian companies play in reviving classic brands.

Sat, Aug 31, 2024